Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pacchetti

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Minerva Medica|January 14, 1986
[Evaluation of the effects of citicoline in chronic cerebrovascular diseases]E Sinforiani, M Trucco, C Pacchetti, et al.
Functional Neurology|May 9, 2002
COMT inhibition and safetyE Martignoni, F Blandini, C Pacchetti, et al.
British Journal of Rheumatology|July 1, 1993
Is Tolosa-Hunt syndrome a limited form of Wegener's granulomatosis? Report of two cases with anti-neutrophil cytoplasmic antibodiesC Montecucco, R Caporali, C Pacchetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 20, 2007
Sleep disorders in Parkinson's disease: facts and new perspectivesR Manni, M Terzaghi, C Pacchetti, et al.
Archives of Gerontology and Geriatrics. Supplement|June 23, 2004
Cognitive rehabilitation in Parkinson's diseaseE Sinforiani, L Banchieri, C Zucchella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 7, 2005
A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic footF Mancini, G Sandrini, A Moglia, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Autonomic disorders in Parkinson's diseaseE Martignoni, C Pacchetti, L Godi, et al.
Functional Neurology|May 19, 1998
Active music therapy and Parkinson's disease: methodsC Pacchetti, R Aglieri, F Mancini, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer typeE Martignoni, F Blandini, F Petraglia, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 9, 1997
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detectionF Blandini, E Martignoni, C Pacchetti, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Minerva Medica|January 14, 1986
[Evaluation of the effects of citicoline in chronic cerebrovascular diseases]E Sinforiani, M Trucco, C Pacchetti, et al.
Functional Neurology|May 9, 2002
COMT inhibition and safetyE Martignoni, F Blandini, C Pacchetti, et al.
British Journal of Rheumatology|July 1, 1993
Is Tolosa-Hunt syndrome a limited form of Wegener's granulomatosis? Report of two cases with anti-neutrophil cytoplasmic antibodiesC Montecucco, R Caporali, C Pacchetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 20, 2007
Sleep disorders in Parkinson's disease: facts and new perspectivesR Manni, M Terzaghi, C Pacchetti, et al.
Archives of Gerontology and Geriatrics. Supplement|June 23, 2004
Cognitive rehabilitation in Parkinson's diseaseE Sinforiani, L Banchieri, C Zucchella, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|May 7, 2005
A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic footF Mancini, G Sandrini, A Moglia, et al.
Journal of Neural Transmission. Supplementum|January 1, 1995
Autonomic disorders in Parkinson's diseaseE Martignoni, C Pacchetti, L Godi, et al.
Functional Neurology|May 19, 1998
Active music therapy and Parkinson's disease: methodsC Pacchetti, R Aglieri, F Mancini, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1992
Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer typeE Martignoni, F Blandini, F Petraglia, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|December 9, 1997
Simultaneous determination of L-dopa and 3-O-methyldopa in human platelets and plasma using high-performance liquid chromatography with electrochemical detectionF Blandini, E Martignoni, C Pacchetti, et al.
Pageof 6